Metavasi Capital’s Blend Labs BLND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-6,385,900
Closed -$19.4M 22
2025
Q4
$19.4M Sell
6,385,900
-336,374
-5% -$1.07M 7.91% 2
2025
Q3
$24.5M Buy
6,722,274
+1,324,115
+25% +$4.75M 7.41% 2
2025
Q2
$17.8M Sell
5,398,159
-155,942
-3% -$528K 7.27% 3
2025
Q1
$18.6M Buy
5,554,101
+750,000
+16% +$2.73M 11.82% 2
2024
Q4
$20.2M Buy
4,804,101
+290,623
+6% +$1.25M 7.15% 3
2024
Q3
$16.9M Sell
4,513,478
-516,209
-10% -$1.71M 7.69% 2
2024
Q2
$11.9M Buy
5,029,687
+1,320,694
+36% +$3.5M 6.22% 2
2024
Q1
$12.1M Buy
3,708,993
+237,798
+7% +$641K 7.01% 2
2023
Q4
$8.85M Buy
3,471,195
+462,625
+15% +$698K 3.44% 10
2023
Q3
$4.12M Buy
3,008,570
+550,000
+22% +$668K 2.32% 14
2023
Q2
$2.33M Buy
2,458,570
+550,000
+29% +$487K 1.52% 21
2023
Q1
$1.9M Buy
1,908,570
+60,819
+3% +$93.2K 1.42% 26
2022
Q4
$2.66M Buy
+1,847,751
New +$3.31M 2.94% 14
2022
Q2
Sell
-166,603
Closed -$950K 26
2022
Q1
$950K Sell
166,603
-1,396,397
-89% -$10.8M 0.51% 26
2021
Q4
$11.5M Buy
+1,563,000
New +$18.1M 1.61% 8

Other funds holding BLND

Metavasi Capital's BLND Position: Q1 2026 in Review

Metavasi Capital sold out of Blend Labs (BLND) in Q1 2026, closing a stake of 6,385,900 shares — an estimated $19.4M sold.

Metavasi Capital first reported a position in BLND in Q4 2021 and held it in 15 quarters. The position peaked at $24.5M in Q3 2025. 194 funds tracked by Wall St. Rank hold BLND as of Q1 2026.

  • Metavasi Capital reported no remaining Blend Labs position as of Q1 2026 after selling out during the quarter.
  • Metavasi Capital sold 6,385,900 Blend Labs shares in Q1 2026, an estimated $19.4M.
  • Metavasi Capital first reported a position in Blend Labs in Q4 2021 and held it in 15 quarters.
  • Metavasi Capital's Blend Labs position peaked at $24.5M in Q3 2025.
  • 194 funds tracked by Wall St. Rank held Blend Labs as of Q1 2026.

Based on Metavasi Capital's 13F filing for Q1 2026, filed 15 May 2026.